Dupixent Litigation
IN RE: Dupixent (Dupilumab) Products Liability Litigation
Overview
The Dupixent Litigation is a federal multidistrict litigation consolidated in the District of New Jersey before Zahid N. Quraishi (U.S. District Judge). This MDL involves claims related to pharmaceutical issues.
As of 2026-08-03, there are 28 pending actions out of 29 total actions filed, representing a 3% resolution rate.
Who May Qualify
Eligibility for this MDL typically depends on factors such as:
- Documented exposure to or use of the product/device in question
- Medical diagnosis of related injuries or conditions
- Claim filed within the applicable statute of limitations
Key Information
Assigned Judge
Zahid N. Quraishi (U.S. District Judge)
District Court
District of New Jersey
MDL Number
MDL-3180
Category
Pharmaceutical
Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.